Immunovant, Inc. Common Stock vs. Twist Bioscience Corporation Common Stock
IMVT
Immunovant, Inc. Common Stock
$37.66 +0.80%
VS TWSTTwist Bioscience Corporation Common Stock
$166.99 +7.35%
Twist Bioscience Corporation Common Stock (TWST) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| IMVT | TWST | |
|---|---|---|
| Market Cap | $7.72 billion | $10.31 billion |
| Revenue (TTM) | — | $431.80 million |
| Net Income (TTM) | — | $-136,717,000 |
TWST leads on 1 of 1 size & scale factors.
Valuation
| IMVT | TWST | |
|---|---|---|
| Price / Book | — | 23.14 |
| Price / Sales | — | 23.89 |
IMVT and TWST split the valuation factors evenly.
Profitability
| IMVT | TWST | |
|---|---|---|
| Net Margin | — | -31.66% |
| Return on Equity | — | -30.67% |
IMVT and TWST split the profitability factors evenly.
Risk & Sentiment
| IMVT | TWST | |
|---|---|---|
| Short Interest | 0.15% | 0.08% |
TWST leads on 1 of 1 risk & sentiment factors.
Dig deeper: IMVT overview, IMVT financials, TWST overview, TWST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.